These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 10912955

  • 1. Effects of combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines.
    Nabha SM, Wall NR, Mohammad RM, Pettit GR, Al-Katib AM.
    Anticancer Drugs; 2000 Jun; 11(5):385-92. PubMed ID: 10912955
    [Abstract] [Full Text] [Related]

  • 2. Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.
    Nabha SM, Mohammad RM, Dandashi MH, Coupaye-Gerard B, Aboukameel A, Pettit GR, Al-Katib AM.
    Clin Cancer Res; 2002 Aug; 8(8):2735-41. PubMed ID: 12171907
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of combretastatin A-4 prodrug in a non-Hodgkin's lymphoma xenograft model: preclinical efficacy.
    Nabha SM, Mohammad RM, Wall NR, Dutcher JA, Salkini BM, Pettit GR, Al-Katib AM.
    Anticancer Drugs; 2001 Jan; 12(1):57-63. PubMed ID: 11272287
    [Abstract] [Full Text] [Related]

  • 4. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q, Bianchi P, Bezwoda WR.
    Anticancer Res; 2000 Jan; 20(4):2561-8. PubMed ID: 10953327
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combretastatin CA-4 and combretastatin derivative induce mitotic catastrophe dependent on spindle checkpoint and caspase-3 activation in non-small cell lung cancer cells.
    Vitale I, Antoccia A, Cenciarelli C, Crateri P, Meschini S, Arancia G, Pisano C, Tanzarella C.
    Apoptosis; 2007 Jan; 12(1):155-66. PubMed ID: 17143747
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Viscum album QuFrF extract with vincristine in an in vitro model of human B cell lymphoma WSU-1.
    Kovacs E, Link S, Toffol-Schmidt U.
    Arzneimittelforschung; 2008 Jan; 58(11):592-7. PubMed ID: 19137911
    [Abstract] [Full Text] [Related]

  • 12. Treatment of a de novo fludarabine resistant-CLL xenograft model with bryostatin 1 followed by fludarabine.
    Mohammad RM, Limvarapuss C, Hamdy N, Dutcher BS, Beck FW, Wall NR, Al-Katib AM.
    Int J Oncol; 1999 May; 14(5):945-50. PubMed ID: 10200346
    [Abstract] [Full Text] [Related]

  • 13. BubR1 is required for the mitotic block induced by combretastatin-A4 and a novel cis-restricted ß-lactam analogue in human cancer cells.
    Greene LM, Carr M, Keeley NO, Lawler M, Meegan MJ, Zisterer DM.
    Int J Mol Med; 2011 May; 27(5):715-23. PubMed ID: 21369694
    [Abstract] [Full Text] [Related]

  • 14. In vitro evaluation of the antineoplastic activity of combretastatin A-4, a natural product from Combretum caffrum (arid shrub).
    el-Zayat AA, Degen D, Drabek S, Clark GM, Pettit GR, Von Hoff DD.
    Anticancer Drugs; 1993 Feb; 4(1):19-25. PubMed ID: 8457709
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Analysis of resveratrol-induced apoptosis in human B-cell chronic leukaemia.
    Roman V, Billard C, Kern C, Ferry-Dumazet H, Izard JC, Mohammad R, Mossalayi DM, Kolb JP.
    Br J Haematol; 2002 Jun; 117(4):842-51. PubMed ID: 12060119
    [Abstract] [Full Text] [Related]

  • 17. The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphoma.
    Maki A, Diwakaran H, Redman B, al-Asfar S, Pettit GR, Mohammad RM, al-Katib A.
    Anticancer Drugs; 1995 Jun; 6(3):392-7. PubMed ID: 7670136
    [Abstract] [Full Text] [Related]

  • 18. Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugs.
    Pettit GR, Lippert JW.
    Anticancer Drug Des; 2000 Jun; 15(3):203-16. PubMed ID: 11049088
    [Abstract] [Full Text] [Related]

  • 19. Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation.
    Wang P, Pavletic ZS, Joshi SS.
    Leuk Lymphoma; 2002 Sep; 43(9):1827-35. PubMed ID: 12685840
    [Abstract] [Full Text] [Related]

  • 20. Combretastatin A-4 analogues as antimitotic antitumor agents.
    Nam NH.
    Curr Med Chem; 2003 Sep; 10(17):1697-722. PubMed ID: 12871118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.